HB-200 arenavirus-based immunotherapy plus pembrolizumab as a first-line treatment of patients with recurrent/metastatic HPV16 positive head and neck cancer Meeting Abstract
| Authors: | Nabell, L.; Ho, A. L.; Posner, M. R.; Neupane, P.; Naqash, A. R.; Wong, S.; Niu, J. J.; Pearson, A. T.; Laux, D.; Adkins, D. R.; Pimentel, A.; Rosenberg, A. J.; Richardson, D. L.; Wong, W.; Kaufmann, T. A.; Katchar, K.; Qing, X.; Iacobucci, C.; Schlienger, K.; Pfister, D. |
| Abstract Title: | HB-200 arenavirus-based immunotherapy plus pembrolizumab as a first-line treatment of patients with recurrent/metastatic HPV16 positive head and neck cancer |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S581 |
| End Page: | S582 |
| Language: | English |
| ACCESSION: | WOS:001087480201255 |
| DOI: | 10.1016/j.annonc.2023.09.2065 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 921P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
